MULTIPLE ENDOCRINE NEOPLASIA SYNDROME TYPE 2B

Course overview

Multiple endocrine neoplasia syndrome type 2 (MEN2), caused by mutations of the RET gene on chromosome 10, is an autosomal dominant syndrome characterized by the development of medullary thyroid carcinoma (MTC). MEN2 has 3 subtypes: MEN2 subtype A (MEN2A), MEN2 subtype B (MEN2B; also called mucosal neuroma syndrome and formerly known as MEN3), and familial medullary thyroid carcinoma (FMTC). This continuing education module is designed to give the reader/learner an increased understanding of MEN2B, its clinical presentation, symptoms, and treatment, and to aid in caring for patients with this diagnosis. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.